Convatec Group (STU:2CV) Net Interest Margin (Bank Only) %


STU:2CV Convatec Group PLC STU:2CV
73 GF Score
Price €2.56
GF Value €2.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Convatec Group Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:2CV
73GF Score
Convatec Group PLC STU:2CV
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Convatec Group (STU:2CV) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of €2.56 is trading 11.4% below its estimated GF Value™ of €2.89. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for STU:2CV:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €2.89 vs. price of €2.56 (11.4% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the STU:2CV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
73GF Score

Get the complete analysis for STU:2CV

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.56
Price
€2.89
GF Value